Microbial Proliferation Analysis Service "BGM Solution"
Achieving optical density measurement in solid culture using a 2D TFT sensor and AI image analysis!
The "BGM Solution" is a microbial growth analysis service that enables the analysis of microbial proliferation by measuring at 1000×1000 pixels every 5 minutes. You can conduct experiments using the BGM provided by our company, and we will return the analysis results. It is effective not only for low molecular compounds but also for the exploration of peptides and bacteriophages. We support the creation of new research fields, such as microbial exploration from various environmental samples and the generation of high-performance strains. Please feel free to contact us when you need our services. 【Features】 ■ Exploration of new antibiotics ■ Exploration of new microorganisms ■ Creation of new research fields *For more details, please download the PDF or feel free to contact us.
basic information
For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Recommended products
Distributors
CarbGeM Inc. provides digital transformation (DX) and AI solutions specialized in the life sciences and healthcare sectors. Building on capabilities in medical data analysis, image-analysis AI, generative AI, and application development, we work together with academia, medical institutions, and companies to support the full journey from research and development through to real-world implementation. We have particular expertise in developing AI-based Software as a Medical Device (SaMD), navigating regulatory affairs, and establishing Quality Management Systems (QMS), backed by a proven track record of obtaining medical device approvals and notifications. We advance industry-academia partnerships around early-stage AI and data-science research emerging from academia, with technical implementation, clinical application, and commercialization firmly in view. We take the same approach with our corporate partners, pursuing co-creation to move research and new business initiatives forward while keeping technical implementation and regulatory requirements in mind. As a partner in joint research and new business development, we would welcome the opportunity to exchange ideas on areas where our expertise can add value—including data-collection design and the preparation of AI-ready data, DX/AI implementation, and the planning of regulatory and exit strategies. We would also be glad to take an active role in securing funding for joint projects.